{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T10:44:54Z","timestamp":1784371494194,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ejphar.2020.173203","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T11:33:14Z","timestamp":1590060794000},"page":"173203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Tyrosine 135 of the \u03b21 subunit as binding site of BAY-543: Importance of the Y-x-S-x-R motif for binding and activation by sGC activator drugs"],"prefix":"10.1016","volume":"881","author":[{"given":"Anne","family":"R\u00fchle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christin","family":"Elgert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sandner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6nke","family":"Behrends","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173203_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057644","article-title":"Crystal structures of the catalytic domain of human soluble guanylate cyclase","volume":"8","author":"Allerston","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2020.173203_bib2","doi-asserted-by":"crossref","first-page":"12880","DOI":"10.1074\/jbc.RA119.009016","article-title":"Heat shock protein 90 regulates soluble guanylyl cyclase maturation by a dual mechanism","volume":"294","author":"Dai","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2020.173203_bib3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bcp.2019.02.007","article-title":"A novel soluble guanylyl cyclase activator, BR 11257, acts as a non-stabilising partial agonist of sGC","volume":"163","author":"Elgert","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173203_bib4","article-title":"Thermal shift assay: strengths and weaknesses of the method to investigate the ligand-induced thermostabilization of soluble guanylyl cyclase","volume":"113065","author":"Elgert","year":"2019","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.ejphar.2020.173203_bib5","doi-asserted-by":"crossref","first-page":"43053","DOI":"10.1074\/jbc.M112.393892","article-title":"Heme-assisted S-nitrosation desensitizes ferric soluble guanylate cyclase to nitric oxide","volume":"287","author":"Fernhoff","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2020.173203_bib6","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1021\/bi301570m","article-title":"Molecular model of a soluble guanylyl cyclase fragment determined by small-angle X-ray scattering and chemical cross-linking","volume":"52","author":"Fritz","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2020.173203_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1209657","article-title":"Riociguat for the treatment of chronic thromboembolic pulmonary hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2020.173203_bib8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2020.173203_bib9","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.1016\/S0021-9258(20)82126-7","article-title":"Regulation of soluble guanylate cyclase activity by porphyrins and metalloporphyrins","volume":"259","author":"Ignarro","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2020.173203_bib10","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.5012\/bkcs.2002.23.11.1511","article-title":"Highly sensitive and fast protein detection with Coomassie brilliant Blue in sodium dodecyl sulfate-polyacrylamide gel electrophoresis","volume":"23","author":"Kang","year":"2002","journal-title":"Bull. Kor. Chem. Soc."},{"key":"10.1016\/j.ejphar.2020.173203_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41586-019-1584-6","article-title":"Structural insights into the mechanism of human soluble guanylate cyclase","volume":"574","author":"Kang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2020.173203_bib12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0167-4781(00)00211-6","article-title":"Cloning and functional expression of the rat \u03b12 subunit of soluble guanylyl cyclase","volume":"1494","author":"Koglin","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2020.173203_bib13","doi-asserted-by":"crossref","first-page":"12590","DOI":"10.1074\/jbc.M212740200","article-title":"A functional domain of the alpha1 subunit of soluble guanylyl cyclase is necessary for activation of the enzyme by nitric oxide and YC-1 but is not involved in heme binding","volume":"278","author":"Koglin","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2020.173203_bib14","doi-asserted-by":"crossref","first-page":"30737","DOI":"10.1074\/jbc.M102549200","article-title":"Nitric oxide activates the beta 2 subunit of soluble guanylyl cyclase in the absence of a second subunit","volume":"276","author":"Koglin","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2020.173203_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1124\/mol.117.109918","article-title":"Irreversible activation and stabilization of soluble guanylate cyclase by the protoporphyrin IX mimetic cinaciguat","volume":"93","author":"Kollau","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173203_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025772","article-title":"The amino-terminus of nitric oxide sensitive guanylyl cyclase \u03b1\u2081 does not affect dimerization but influences subcellular localization","volume":"6","author":"Kraehling","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2020.173203_bib17","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1021\/bi301657w","article-title":"Insights into BAY 60-2770 activation and S-nitrosylation-dependent desensitization of soluble guanylyl cyclase via crystal structures of homologous nostoc H-NOX domain complexes","volume":"52","author":"Kumar","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2020.173203_bib18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1472-6807-10-2","article-title":"Crystal structure of the signaling helix coiled-coil domain of the beta1 subunit of the soluble guanylyl cyclase","volume":"10","author":"Ma","year":"2010","journal-title":"BMC Struct. Biol."},{"key":"10.1016\/j.ejphar.2020.173203_bib19","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1074\/jbc.M706218200","article-title":"PAS-mediated dimerization of soluble guanylyl cyclase revealed by signal transduction histidine kinase domain crystal structure","volume":"283","author":"Ma","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2020.173203_bib20","doi-asserted-by":"crossref","first-page":"22651","DOI":"10.1074\/jbc.M110.111559","article-title":"Structure of cinaciguat (BAY 58-2667) bound to Nostoc H-NOX domain reveals insights into heme-mimetic activation of the soluble guanylyl cyclase","volume":"285","author":"Martin","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2020.173203_bib21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0140-6736(02)46032-1","article-title":"NITRO-GLYCERINE as a remedy for angina pectoris","volume":"113","author":"Murrell","year":"1879","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2020.173203_bib22","doi-asserted-by":"crossref","first-page":"12854","DOI":"10.1073\/pnas.0405188101","article-title":"Crystal structure of an oxygen-binding heme domain related to soluble guanylate cyclases","volume":"101","author":"Pellicena","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2020.173203_bib23","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1167\/iovs.18-23772","article-title":"A novel selective soluble guanylate cyclase activator, MGV354, lowers intraocular pressure in preclinical models, following topical ocular dosing","volume":"59","author":"Prasanna","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejphar.2020.173203_bib24","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/pro.2331","article-title":"Crystal structure of the Alpha subunit PAS domain from soluble guanylyl cyclase","volume":"22","author":"Purohit","year":"2013","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejphar.2020.173203_bib25","doi-asserted-by":"crossref","first-page":"8948","DOI":"10.1021\/jm400539d","article-title":"Insights into soluble guanylyl cyclase activation derived from improved heme-mimetics","volume":"56","author":"Rekowski","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173203_bib26","doi-asserted-by":"crossref","first-page":"12312","DOI":"10.1073\/pnas.0703944104","article-title":"Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation","volume":"104","author":"Sayed","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2020.173203_bib27","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1124\/mol.105.018747","article-title":"Biochemistry and pharmacology of novel anthranilic acid derivatives activating heme-oxidized soluble guanylyl cyclase","volume":"69","author":"Schindler","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173203_bib28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejphar.2005.02.046","article-title":"Residues stabilizing the heme moiety of the nitric oxide sensor soluble guanylate cyclase","volume":"513","author":"Schmidt","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173203_bib29","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1074\/jbc.M310141200","article-title":"Identification of residues crucially involved in the binding of the heme moiety of soluble guanylate cyclase","volume":"279","author":"Schmidt","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2020.173203_bib30","series-title":"Methods of Enzymatic Analysis: Guanylate Cyclase GTP Pyrophosphate-Lyase (Cyclizing)","first-page":"379","year":"1984"},{"key":"10.1016\/j.ejphar.2020.173203_bib32","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.bbapap.2018.03.010","article-title":"Synergistic stabilisation of NOsGC by cinaciguat and non-hydrolysable nucleotides: evidence for sGC activator-induced communication between the heme-binding and catalytic domains","volume":"1866","author":"S\u00f6mmer","year":"2018","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2020.173203_bib33","first-page":"10","article-title":"BAY 60-2770 activates two isoforms of nitric oxide sensitive guanylyl cyclase: evidence for stable insertion of activator drugs","author":"S\u00f6mmer","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173203_bib34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ajo.2018.05.015","article-title":"A randomized, controlled phase I\/II study to evaluate the safety and efficacy of MGV354 for ocular hypertension or glaucoma","volume":"192","author":"Stacy","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ejphar.2020.173203_bib35","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/sj.bjp.0704778","article-title":"NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle","volume":"136","author":"Stasch","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173203_bib36","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1172\/JCI28371","article-title":"Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels","volume":"116","author":"Stasch","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2020.173203_bib37","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/cbic.201100809","article-title":"Insight into the rescue of oxidized soluble guanylate cyclase by the activator cinaciguat","volume":"13","author":"Surmeli","year":"2012","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejphar.2020.173203_bib38","first-page":"384","article-title":"Isolierung und Kristallisation des G\u00e4rungsferments Enolase","author":"Warburg","year":"1941","journal-title":"Biochem. Z."},{"key":"10.1016\/j.ejphar.2020.173203_bib39","doi-asserted-by":"crossref","first-page":"H1763","DOI":"10.1152\/ajpheart.51.2008","article-title":"Soluble guanylyl cyclase activation by HMR-1766 (ataciguat) in cells exposed to oxidative stress","volume":"295","author":"Zhou","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920302958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920302958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:39:21Z","timestamp":1757975961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920302958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":38,"alternative-id":["S0014299920302958"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173203","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tyrosine 135 of the \u03b21 subunit as binding site of BAY-543: Importance of the Y-x-S-x-R motif for binding and activation by sGC activator drugs","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173203","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173203"}}